Statins for the prevention of dementia

Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series

(2008) · doi:10.1002/9780470712184 · Cited by 25,048 · see citing works

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · see citing works

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992 · see citing works

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

(2005) · The Lancet · doi:10.1016/s0140-6736(05)67394-1 · Cited by 6,848 · see citing works

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404 · see citing works

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378 · see citing works

High-Dose Atorvastatin after Stroke or Transient Ischemic Attack

The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061894 · Cited by 2,887 · see citing works

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

Brookmeyer, R., Gray, S. G., & Kawas, C. H. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,774 · see citing works

Statins and the risk of dementia

Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S. S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,763 · see citing works

CNS synaptogenesis promoted by glia-derived cholesterol

Mauch, D. H., Nägler, K., Schumacher, S., Göritz, C., Müller, E.-C., Otto, A., & Pfrieger, F. W. (2001) · Science · doi:10.1126/science.294.5545.1354 · Cited by 1,711 · see citing works

Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>

Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590 · see citing works

Decreased Prevalence of Alzheimer Disease Associated With 3-Hydroxy-3-Methyglutaryl Coenzyme A Reductase Inhibitors

Wolozin, B. L. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1439 · Cited by 1,401 · see citing works

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363 · see citing works

Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons

Simons, M., Keller, P., Strooper, B. D., Beyreuther, K. T., Dotti, C. G., & Simons, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6460 · Cited by 1,167 · see citing works

Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts

Ehehalt, R., Keller, P., Haass, C., Thiele, C., & Simons, K. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207113 · Cited by 1,107 · see citing works

Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo

Fassbender, K. C., Simons, M., Bergmann, C., Stroick, M., Lütjohann, D., Keller, P., Runz, H., Kühl, S., Bertsch, T., von Bergmann, K., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081620098 · Cited by 1,078 · see citing works

Cerebral white matter lesions, vascular risk factors, and cognitive function in a population‐based study

Breteler, M. M. B., Swieten, J. C. V., Bots, M. L., Grobbee, D. E., Claus, J. J., Hout, J. H. W. V. D., van Harskamp, F., Tanghe, H. L. J., de Jong, P. T. V. M., van Gijn, J., et al. (1994) · Neurology · doi:10.1212/wnl.44.7.1246 · Cited by 1,006 · see citing works

Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model

Refolo, L. M., Pappolla, M. A., Malester, B., LaFrancois, J. J., Bryant‐Thomas, T., Wang, R., Tint, G. S., Sambamurti, K., & Duff, K. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0304 · Cited by 1,003 · see citing works

Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study

Yoshitake, T., Kiyohara, Y., Kato, I., Ohmura, T., Iwamoto, H., Nakayama, K., Ohmori, S., Nomiyama, K., Kawano, H., Ueda, K., et al. (1995) · Neurology · doi:10.1212/wnl.45.6.1161 · Cited by 829 · see citing works

High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules

COCKERILL, G. W., Rye, K., Gamble, J. R., Vadas, M. A., & Barter, P. J. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.1987 · Cited by 782 · see citing works

Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation

Lütjohann, D., Breuer, O., Ahlborg, G., Nennesmo, I., Sidén, A., Diczfalusy, U., & Björkhem, I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9799 · Cited by 682 · see citing works

Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease

Notkola, I.-L., Sulkava, R. O., Pekkanen, J., Erkinjuntti, T., Ehnholm, C., Kivinen, P., Tuomilehto, J., & Nissinen, A. (1998) · Neuroepidemiology · doi:10.1159/000026149 · Cited by 666 · see citing works

Apolipoprotein E ε4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease

Kivipelto, M., Helkala, E., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Iivonen, S., Mannermaa, A., Tuomilehto, J., Nissinen, A. M., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-3-200208060-00006 · Cited by 645 · see citing works

Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles

Thiele, C., Hannah, M. J., Fahrenholz, F., & Huttner, W. Β. (1999) · Nature Cell Biology · doi:10.1038/71366 · Cited by 571 · see citing works

Type 2 diabetes mellitus, cognitive impairment and dementia

Stewart, R., & Liolitsa, D. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00027.x · Cited by 562 · see citing works

Induction of Alzheimer-like β-Amyloid Immunoreactivity in the Brains of Rabbits with Dietary Cholesterol

Sparks, D. L., Scheff, S. W., Hunsaker, J. C., Liu, H., Landers, T. M., & Gross, D. R. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1044 · Cited by 559 · see citing works

The Alzheimer's disease Beta-secretase enzyme, BACE1

Cole, S. L., & Vassar, R. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-22 · Cited by 550 · see citing works

Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation

Björkhem, I., Lütjohann, D., Diczfalusy, U., Ståhle, L., Ahlborg, G., & Wahren, J. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32188-x · Cited by 538 · see citing works

Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study

Ott, A., Slooter, A., Hofman, A., van Harskamp, F., Witteman, J., Van Broeckhoven, C., van Duijn, C., & Breteler, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07541-7 · Cited by 535 · see citing works

Use of Lipid-Lowering Agents, Indication Bias, and the Risk of Dementia in Community-Dwelling Elderly People

Rockwood, K. J., Kirkland, S., Hogan, D. B., MacKnight, C., Merry, H. R., Verreault, R., Wolfson, C. M., & McDowell, I. (2002) · Archives of Neurology · doi:10.1001/archneur.59.2.223 · Cited by 517 · see citing works

HMG-CoA Reductase Inhibitors Improve Endothelial Dysfunction in Normocholesterolemic Hypertension via Reduced Production of Reactive Oxygen Species

Waßmann, S., Laufs, U., Bäumer, A. T., Müller, K., Ahlbory, K., Linz, W., Itter, G., Rösen, R., Böhm, M., & Nickenig, G. (2001) · Hypertension · doi:10.1161/01.hyp.37.6.1450 · Cited by 458 · see citing works

The design of a prospective study of pravastatin in the elderly at risk (PROSPER)

Shepherd, J., Blauw, G. J., Murphy, M. B., Cobbe, S. M., Bollen, E. L. E. M., Buckley, B. M., Ford, I., Jukema, J. W., Hyland, M., Gaw, A., et al. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00533-0 · Cited by 449 · see citing works

Cholesterol Modulates α-Secretase Cleavage of Amyloid Precursor Protein

Bodovitz, S., & Klein, W. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4436 · Cited by 447 · see citing works

Serum Lipoprotein Levels, Statin Use, and Cognitive Function in Older Women

Yaffe, K. S., Barrett-Connor, E. L., Lin, F., & Grady, D. G. (2002) · Archives of Neurology · doi:10.1001/archneur.59.3.378 · Cited by 439 · see citing works

Association of γ-Secretase with Lipid Rafts in Post-Golgi and Endosome Membranes

Vetrivel, K. S., Cheng, H., Lin, W., Sakurai, T., Li, T., Nukina, N., Wong, P. C., Xu, H., & Thinakaran, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407986200 · Cited by 413 · see citing works

Relation of Plasma Lipids to Alzheimer Disease and Vascular Dementia

Reitz, C., Tang, M.-X., Luchsinger, J., & Mayeux, R. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.705 · Cited by 397 · see citing works

Donepezil in vascular dementia: A randomized, placebo-controlled study

Wilkinson, D., Doody, R., Helme, R., Taubman, K., Mintzer, J., Kertesz, A., Pratt, R. D., & the Donepezil 308 Study Group* (2003) · Neurology · doi:10.1212/01.wnl.0000078943.50032.fc · Cited by 392 · see citing works

Efficacy and Tolerability of Donepezil in Vascular Dementia: Positive Results of a 24-Week, Multicenter, International, Randomized, Placebo-Controlled Clinical Trial

Black, S., Román, G. C., Geldmacher, D. S., Salloway, S., Hecker, J., Burns, A., Perdomo, C., Kumar, D., & Pratt, R. (2003) · Stroke · doi:10.1161/01.str.0000091396.95360.e1 · Cited by 386 · see citing works

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease

Wolozin, B. L., Wang, S. W., Li, N.-C., Lee, A. F., Lee, T. A., & Kazis, L. E. (2007) · BMC Medicine · doi:10.1186/1741-7015-5-20 · Cited by 385 · see citing works

Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients

Lütjohann, D., Papassotiropoulos, A., Björkhem, I., Locatelli, S., Bagli, M., Oehring, R. D., Schlegel, U. S., Jessen, F., Rao, M. L., von Bergmann, K., et al. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32052-6 · Cited by 378 · see citing works

Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease

Jarvik, G. P., Wijsman, E. M., Kukull, W. A., Schellenberg, G. D., Yu, C., & Larson, E. B. (1995) · Neurology · doi:10.1212/wnl.45.6.1092 · Cited by 371 · see citing works

Statin‐Associated Memory Loss: Analysis of 60 Case Reports and Review of the Literature

Wagstaff, L. R., Mitton, M. W., McLendon-Arvik, B., & Doraiswamy, P. M. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.7.871.32720 · Cited by 365 · see citing works

Isoprenoids as mediators of the biological effects of statins

Liao, J. K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216421 · Cited by 352 · see citing works

Neuropathological assessment of the lesions of significance in vascular dementia

Esiri, M. M., Wilcock, G. K., & Morris, J. H. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.6.749 · Cited by 347 · see citing works

The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function

Posner, H. B., Tang, M. X., Luchsinger, J. A., Lantigua, R., Stern, Y., & Mayeux, R. P. (2002) · Neurology · doi:10.1212/wnl.58.8.1175 · Cited by 330 · see citing works

Do Statins Reduce Risk of Incident Dementia and Alzheimer Disease? The Cache County Study

Zandi, P. P. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.2.217 · Cited by 308 · see citing works

Effects of lovastatin on cognitive function and psychological well-being

Muldoon, M. F., Barger, S. D., Ryan, C. M., Flory, J. D., Lehoczky, J. P., Matthews, K. A., & Manuck, S. B. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00353-3 · Cited by 290 · see citing works

Statin Use and the Risk of Incident Dementia

Rea, T. D., Breitner, J. C. S., Psaty, B. M., Fitzpatrick, A. L., López, O. L., Newman, A. B., Hazzard, W. R., Zandi, P. P., Burke, G. L., Lyketsos, C. G., et al. (2005) · Archives of Neurology · doi:10.1001/archneur.62.7.1047 · Cited by 277 · see citing works

Cholesterol and Alzheimer’s disease

Simons, M., Keller, P., DICHGANS, J., & Schulz, J. B. (2001) · Neurology · doi:10.1212/wnl.57.6.1089 · Cited by 258 · see citing works

Regulation of endoplasmic reticulum cholesterol by plasma membrane cholesterol

Lange, Y., Ye, J., Rigney, M., & Steck, T. L. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32101-5 · Cited by 248 · see citing works

Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults

Muldoon, M. F., Ryan, C. M., Sereika, S. M., Flory, J. D., & Manuck, S. B. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.07.041 · Cited by 247 · see citing works

Statin therapy and risk of dementia in the elderly

Li, G., Higdon, R., Kukull, W. A., Peskind, E. R., Moore, K. V. V., Tsuang, D. W., van Belle, G., McCormick, W. C., Bowen, J. D., Teri, L. L., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000142963.90204.58 · Cited by 246 · see citing works

Lipid-lowering drugs

Pahan, K. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5406-7 · Cited by 241 · see citing works

Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease

Li, G., Larson, E. B., Sonnen, J. A., Shofer, J. B., Petrie, E. C., Schantz, A. M., Peskind, E. R., Raskind, M. A., Breitner, J. C. S., & Montine, T. J. (2007) · Neurology · doi:10.1212/01.wnl.0000277657.95487.1c · Cited by 237 · see citing works

APOE genotype, cholesterol level, lipid-lowering treatment, and dementia

Dufouil, C., Richard, F., Fiévet, N., Dartigues, J., Ritchie, K. A., Tzourio, C., Amouyel, P., & Alpérovitch, A. (2005) · Neurology · doi:10.1212/01.wnl.0000160114.42643.31 · Cited by 229 · see citing works

Low-Density Lipoprotein Cholesterol and the Risk of Dementia With Stroke

Moroney, J. T. (1999) · JAMA · doi:10.1001/jama.282.3.254 · Cited by 222 · see citing works

Amyloidogenic processing of β-amyloid precursor protein in intracellular compartments

Vetrivel, K. S., & Thinakaran, G. (2006) · Neurology · doi:10.1212/01.wnl.0000192107.17175.39 · Cited by 217 · see citing works

Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study.

Sharrett, A. R., Patsch, W., Sorlie, P. D., HEISS, G. M., Bond, M. G., & DAVIS, C. E. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.7.1098 · Cited by 214 · see citing works

Association between Statin Use and Alzheimer’s Disease

ZAMRINI, E. Y., McGwin, G., & Roseman, J. M. (2004) · Neuroepidemiology · doi:10.1159/000073981 · Cited by 201 · see citing works

Statins, incident Alzheimer disease, change in cognitive function, and neuropathology

Arvanitakis, Z., Schneider, J. A., Wilson, R. S., Bienias, J. L., Kelly, J. F., Evans, D. A., & Bennett, D. A. (2008) · Neurology · doi:10.1212/01.wnl.0000288181.00826.63 · Cited by 199 · see citing works

Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain

Näslund, J., Thyberg, J., Tjernberg, L. O., Wernstedt, C., Karlström, A. R., Bogdanović, N., Gandy, S., Lannfelt, L., Terenius, L. Y., & Nordstedt, C. (1995) · Neuron · doi:10.1016/0896-6273(95)90079-9 · Cited by 189 · see citing works

Association between high‐density lipoprotein and cognitive impairment in the oldest old

van Exel, E. R., de Craen, A. J. M., Gussekloo, J., Houx, P. J., Wiel, A. B. D., Macfarlane, P. W., Blauw, G. J., & Westendorp, R. G. J. (2002) · Annals of Neurology · doi:10.1002/ana.10220 · Cited by 189 · see citing works

The Impact of the Use of Statins on the Prevalence of Dementia and the Progression of Cognitive Impairment

Hajjar, I. M., Schumpert, J., Hirth, V., Wieland, D. M., & Eleazer, G. P. (2002) · The Journals of Gerontology Series A · doi:10.1093/gerona/57.7.m414 · Cited by 188 · see citing works

Status of Risk Factors for Vascular Dementia

Skoog, I. G. (1998) · Neuroepidemiology · doi:10.1159/000026147 · Cited by 176 · see citing works

Serum Cholesterol and Cognitive Performance in the Framingham Heart Study

Elias, P. K., Elias, M. F., D’Agostino, R. B., SULLIVAN, L. M., & Wolf, P. A. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000151745.67285.c2 · Cited by 168 · see citing works

Is Alzheimer's disease an apolipoprotein E amyloidosis?

Wisniewski, T., Lalowski, M., Golabek, A., Frangione, B., & Vogel, T. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90701-7 · Cited by 155 · see citing works

Cognitive Impairment Associated with Atorvastatin and Simvastatin

King, D. S., Wilburn, A. J., Wofford, M. R., Harrell, T. K., Lindley, B. J., & Jones, D. W. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.15.1663.31953 · Cited by 152 · see citing works

Removal of cholesterol from extrahepatic sources by oxidative mechanisms

Björkhem, I., Diczfalusy, U., & Lütjohann, D. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199904000-00010 · Cited by 131 · see citing works

Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial

Sparks, D. L., Connor, D. J., Sabbagh, M. N., Petersen, R. B., Lopez, J., & Browne, P. J. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00690.x · Cited by 130 · see citing works

Alzheimer's Disease: cholesterol, membrane rafts, isoprenoids and statins

Reid, P., Urano, Y., Kodama, T., & Hamakubo, T. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00054.x · Cited by 129 · see citing works

Association Between Apolipoprotein E 4 and Cognitive Decline in Elderly Adults

Packard, C. J., Westendorp, R. G. J., Stott, D. J., CASLAKE, M. J., Murray, H. M., Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L. E. M., Buckley, B. M., et al. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01415.x · Cited by 127 · see citing works

Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis

Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124 · see citing works

Reduced Risk of Incident AD with Elective Statin Use in a Clinical Trial Cohort

Sparks, D. L., Kryscio, R. J., Sabbagh, M., Connor, D. J., Sparks, L. M., & Liebsack, C. (2008) · Current Alzheimer Research · doi:10.2174/156720508785132316 · Cited by 121 · see citing works

Cholesterol-dependent Generation of a Seeding Amyloid β-Protein in Cell Culture

Mizuno, T., Nakata, M., Naiki, H., Michikawa, M., Wang, R., Haass, C., & Yanagisawa, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.15110 · Cited by 117 · see citing works

Co-localization of cholesterol, apolipoprotein E and fibrillar Aβ in amyloid plaques

Burns, M. P., Noble, W. J., Olm, V., Gaynor, K., Casey, E., LaFrancois, J. J., Wang, L., & Duff, K. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00647-2 · Cited by 115 · see citing works

Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia

Paragh, G., Balla, P., Katona, E., Seres, I., Égerházi, A., & Degrell, I. (2002) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060200013 · Cited by 113 · see citing works

Effect of Pharmacologic Lipid Lowering on Health‐Related Quality of Life in Older Persons: Results from the Cholesterol Reduction in Seniors Program (CRISP) Pilot Study

Santanello, N. C., Barber, B., Applegate, W. B., Elam, J. T., Curtis, C., Hunninghake, D. B., Gordon, D. J., & For the CRISP Collaborative Study Group (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb00971.x · Cited by 101 · see citing works

Statins for the prevention of Alzheimer's disease and dementia

Scott, H. D., & Laake, K. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003160 · Cited by 91 · see citing works

High density lipoproteins reduce organ injury and organ dysfunction in a rat model of hemorrhagic shock

COCKERILL, G. W., McDonald, M. C., Mota‐Filipe, H., Cuzzocrea, S., Miller, N. E., & Thiemermann, C. (2001) · The FASEB Journal · doi:10.1096/fj.01-0075com · Cited by 90 · see citing works

Use of Lipid‐Lowering Drugs in Older Adults With and Without Dementia: A Community‐Based Epidemiological Study

Rodríguez, E., Dodge, H. H., Birzescu, M., Stoehr, G. P., & Ganguli, M. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50515.x · Cited by 90 · see citing works

Neuropathological Substrates of Dementia and Depression in Vascular Dementia, with a Particular Focus on Cases with Small Infarct Volumes

Ballard, C. G., McKeith, I. G., O'Brien, J. T., Kalaria, R. N., Jaros, E., Ince, P. G., & Perry, R. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017215 · Cited by 89 · see citing works

Vascular factors in dementia: an overview

DeCarli, C. S. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.09.005 · Cited by 87 · see citing works

Serum Cholesterol and Intellectual Performance

Muldoon, M. F., Ryan, C. M., Matthews, K. A., & Manuck, S. B. (1997) · Psychosomatic Medicine · doi:10.1097/00006842-199707000-00008 · Cited by 83 · see citing works

Statin treatment alters serum n-3 and n-6 fatty acids in hypercholesterolemic patients

Harris, J. I., Hibbeln, J. R., Mackey, R. H., & Muldoon, M. F. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.06.001 · Cited by 82 · see citing works

Is There a Connection Between the Concentration of Cholesterol Circulating in Plasma and the Rate of Neuritic Plaque Formation in Alzheimer Disease?

Haley, R. W. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1410 · Cited by 75 · see citing works

The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): Design and baseline characteristics

Jones, R. W., Kivipelto, M., Feldman, H., Sparks, L. D., Doody, R. S., Waters, D. D., Hey‐Hadavi, J., Breazna, A., Schindler, R. J., Ramos, H., et al. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.02.001 · Cited by 71 · see citing works

HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN DIFFERENTIAL DIAGNOSIS OF SENILE DEMENTIA

Muckle, T. J., & Roy, J. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92866-1 · Cited by 67 · see citing works

The Role of Cholesterol and Statins in Alzheimer's Disease

Miller, L. J., & Chacko, R. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d104 · Cited by 63 · see citing works

QKI expression is regulated during neuron-glial cell fate decisions

Hardy, R. J. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981001)54:1 · Cited by 60 · see citing works

Plasma antioxidant activity and vascular dementia

Ryglewicz, D., RODO, M., Kunicki, P. K., Bednarska‐Makaruk, M., Graban, A., Łojkowska, W., & Wehr, H. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00290-3 · Cited by 57 · see citing works

Cholesterol Lowering in the Elderly

LaRosa, J. C. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420050081008 · Cited by 56 · see citing works

Paraoxonase 1 Activity: A New Vascular Marker of Dementia?

DANTOINE, T. F., Debord, J., Merle, L., LACROIX‐RAMIANDRISOA, H., Bernard‐Bourzeix, L., & Charmes, J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04802.x · Cited by 55 · see citing works

Subchronic Toxicity of Atorvastatin, a Hydroxymethylglutaryl-Coenzyme A Reductase Inhibitor, in Beagle Dogs

Walsh, K. M., Albassam, M., & Clarke, D. E. (1996) · Toxicologic Pathology · doi:10.1177/019262339602400409 · Cited by 54 · see citing works

Effects of simvastatin on the metabolism of polyunsaturated fatty acids and on glycerolipid, cholesterol, and de novo lipid synthesis in THP-1 cells

Risé, P., Colombo, C., & Galli, C. L. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37414-9 · Cited by 50 · see citing works

Enhanced oxidizability of ubiquinol and α‐tocopherol during lovastatin treatment

Palomäki, A., Malminiemi, K., & Metsä‐Ketelä, T. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00609-1 · Cited by 49 · see citing works

Serum cholesterol concentrations are associated with visuomotor speed in men: findings from the third National Health and Nutrition Examination Survey, 1988–1994

Zhang, J., Muldoon, M. F., & McKeown, R. E. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.2.291 · Cited by 45 · see citing works

Brain and optic system pathology in hypocholesterolemic dogs treated with a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.

Berry, P. H., MacDonald, J. S., ALBERTS, A. W., Molon-Noblot, S., Chen, J. S., Lo, C. Y., Greenspan, M. D., Allen, H., Durand-Cavagna, G., & Jensen, R. (1988) · PubMed Central · Cited by 41 · see citing works

Lipoprotein profile in older patients with vascular dementia and Alzheimer's disease

Zuliani, G., Blè, A., Zanca, R., Munari, M. R., Zurlo, A., Vavalle, C., Atti, A. R., & Fellin, R. (2001) · BMC Geriatrics · doi:10.1186/1471-2318-1-5 · Cited by 35 · see citing works

Apolipoprotein E alleles and hyperlipoproteinemia in Japan

Eto, M., Watanabe, K., & Ishii, K. K. (1988) · Clinical Genetics · doi:10.1111/j.1399-0004.1988.tb02871.x · Cited by 23 · see citing works

[Vascular dementia and systemic changes].

Klich‐Rączka, A., Nęcki, M., Wizner, B., Baron, T., Adamkiewicz-Piejko, A., Gryglewska, B., & Grodzicki, T. K. (2002) · PubMed · Cited by 11 · see citing works

APP Processing Enzymes (Secretases) as Therapeutic Targets: Insights from the Use of Transgenics (Tgs) and Transfected Cells

Marks, N., & Berg, M. J. (2003) · Neurochemical Research · doi:10.1023/a:1023211323853 · Cited by 11 · see citing works

New Possible Role of Statins in Age‐Related Diseases

Ruocco, A., Postiglione, A., Santillo, M., Serù, R., Avvedimento, E. V., Cuda, G., & Paternò, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50631.x · Cited by 11 · see citing works

Statins for the treatment of Alzheimer's disease and dementia

McGuinness, B., Bullock, R. A., Craig, D., Kerr, E., & Passmore, P. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007514 · Cited by 6 · see citing works

Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.

(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2 · see citing works

Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811 · see citing works

Alzheimer's disease

Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61349-9 · Cited by 2,336 · see citing works

Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population‐based perspective

Baumgart, M., Snyder, H. M., Carrillo, M. C., Fazio, S., Kim, H., & Johns, H. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.05.016 · Cited by 1,660 · see citing works

A commentary on studies presenting projections of the future prevalence of dementia

Norton, S., Matthews, F. E., & Brayne, C. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-1 · Cited by 634 · see citing works

The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation

Andrade, J. G., Aguilar, M., Atzema, C. L., Bell, A., Cairns, J. A., Cheung, C. C., Cox, J. L., Dorian, P., Gladstone, D. J., Healey, J. S., et al. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.09.001 · Cited by 568 · see citing works

Epidemiology of Dementias and Alzheimer’s Disease

Sosa, A. L., Acosta, I., & Prince, M. J. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.11.003 · Cited by 553 · see citing works

Surgery, neuroinflammation and cognitive impairment

Alam, A., Hana, Z., Jin, Z., Suen, K. C., & Ma, D. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.10.021 · Cited by 483 · see citing works

Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis

Santos, C. Y., Snyder, P. J., Wu, W., Zhang, M., Echeverria, A., & Alber, J. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.01.005 · Cited by 431 · see citing works

Survival in dementia and predictors of mortality: a review

Todd, S., Barr, S., Roberts, M., & Passmore, A. P. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3946 · Cited by 417 · see citing works

EFNS guidelines for the diagnosis and management of Alzheimer's disease

Hort, J., O’Brien, J. T., Gainotti, G., Pirttila, T., Popescu, B. O., Rektorova, I., Sorbi, S., Scheltens, P., & Dementia, O. B. O. T. E. S. P. O. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03040.x · Cited by 490 · see citing works

Cognitive function, dementia and type 2 diabetes mellitus in the elderly

Strachan, M. W. J., Reynolds, R. M., Marioni, R. E., & Price, J. F. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.228 · Cited by 402 · see citing works

Review: Systemic inflammation and<scp>A</scp>lzheimer's disease

Holmes, C. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01307.x · Cited by 356 · see citing works

Advances in the prevention of Alzheimer's disease and dementia

Solomon, A., Mangialasche, F., Richard, E., Andrieu, S., Bennett, D., Breteler, M. M. B., Fratiglioni, L., Hooshmand, B., Khachaturian, A. S., Schneider, L. S. S., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12178 · Cited by 316 · see citing works

Advances in developing novel therapeutic strategies for Alzheimer’s disease

Cao, J., Hou, J., Ping, J., & Cai, D. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0299-8 · Cited by 283 · see citing works

Therapies for Prevention and Treatment of Alzheimer’s Disease

Mendiola-Precoma, J., Berumen, L. C., Padilla, K., & García‐Alcocer, G. (2016) · BioMed Research International · doi:10.1155/2016/2589276 · Cited by 245 · see citing works

Do Statins Impair Cognition? A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Ott, B. R., Daiello, L. A., Dahabreh, I. J., Springate, B. A., Bixby, K., Murali, M., & Trikalinos, T. A. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-014-3115-3 · Cited by 240 · see citing works

Statins for the treatment of dementia

McGuinness, B., Craig, D., Bullock, R. A., Malouf, R. S., & Passmore, P. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007514.pub3 · Cited by 232 · see citing works

Mild Cognitive Impairment and Dementia

Etgen, T., Sander, D., Bickel, H., & Förstl, H. (2011) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2011.0743 · Cited by 210 · see citing works

Lipid Rafts and Alzheimer’s Disease: Protein-Lipid Interactions and Perturbation of Signaling

Hicks, D. A., Nalivaeva, N. N., & Turner, A. J. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00189 · Cited by 205 · see citing works

Geographical variation in dementia: Systematic review with meta-analysis

Russ, T. C., Batty, G. D., Hearnshaw, G. F., Fenton, C., & Starr, J. M. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys103 · Cited by 191 · see citing works

Drug delivery to the brain in Alzheimer's disease: Consideration of the blood–brain barrier

Banks, W. A. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.005 · Cited by 184 · see citing works

Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Proceedings of a Canadian Working Group Consensus Conference

Mancini, G. B. J., Baker, S. K., Bergeron, J., FITCHETT, D. H., Frohlich, J. J., Genest, J. J., Gupta, M., Hegele, R. A., Ng, D. S., & Pope, J. E. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.05.007 · Cited by 184 · see citing works

Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease

Yao, J., Ho, D. J., Calingasan, N. Y., Pipalia, N. H., Lin, M. T. S., & Beal, M. F. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20121239 · Cited by 159 · see citing works

Statins, cognition, and dementia-systematic review and methodological commentary

Power, M. C., Weuve, J., Sharrett, A. R., Blacker, D., & Gottesman, R. F. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.35 · Cited by 150 · see citing works

Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia

Roher, A. E., Tyas, S. L., Maarouf, C. L., Daugs, I. D., Kokjohn, T. A., Emmerling, M. R., Garami, Z. F., Bëlohlávek, M., Sabbagh, M. N., Sue, L. I., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.08.228 · Cited by 144 · see citing works

Low-density lipoprotein receptor-related protein 1: A physiological Aβ homeostatic mechanism with multiple therapeutic opportunities

Sagare, A. P., Deane, R., & Zloković, B. V. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.07.008 · Cited by 144 · see citing works

Vascular Cognitive Impairment: Disease Mechanisms and Therapeutic Implications

Levine, D. A., & Langa, K. M. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0047-z · Cited by 130 · see citing works

Statins for the prevention of dementia

McGuinness, B., Craig, D., Bullock, R., & Passmore, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003160.pub3 · Cited by 490 · see citing works

Does atrial fibrillation cause cognitive decline and dementia?

Dietzel, J., Hæusler, K. G., & Endres, M. (2017) · EP Europace · doi:10.1093/europace/eux031 · Cited by 129 · see citing works

Risk of Dementia in Seniors With Newly Diagnosed Diabetes: A Population-Based Study

Haroon, N. N., Austin, P. C., Shah, B. R., Wu, J., Gill, S. S., & Booth, G. L. (2015) · Diabetes Care · doi:10.2337/dc15-0491 · Cited by 126 · see citing works

Statins in the prevention of dementia and Alzheimer's disease: A meta‐analysis of observational studies and an assessment of confounding

Wong, W. B., Lin, V. W., Boudreau, D. M., & Devine, E. B. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3381 · Cited by 124 · see citing works

Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot ‘Prevention of Decline in Cognition after Stroke Trial’ (PODCAST) Randomised Controlled Trial

Bath, P. M., Scutt, P., Blackburn, D. J., Ankolekar, S., Krishnan, K., Ballard, C. G., Burns, A. S., Mant, J., Passmore, P., Pocock, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0164608 · Cited by 103 · see citing works

Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer's Disease

Karakaya, T., Fußer, F., Schröder, J., & Pantel, J. (2013) · Current Neuropharmacology · doi:10.2174/157015913804999487 · Cited by 103 · see citing works

Impact of cardiovascular risk factors on cognitive function: The Tromsø study

Arntzen, K. A., Schirmer, H., Wilsgaard, T., & Mathiesen, E. B. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03263.x · Cited by 101 · see citing works

Statins and Cognitive Functioning in the Elderly: A Population-Based Study

Benito‐León, J., Louis, E. D., Vega, S., & Bermejo‐Pareja, F. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100180 · Cited by 97 · see citing works

Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review

Ligthart, S. A., Richard, E., van Charante, M., & van Gool, W. A. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s7343 · Cited by 96 · see citing works

Genetic connections between neurological disorders and cholesterol metabolism

Björkhem, I., Leoni, V., & Meaney, S. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r006338 · Cited by 92 · see citing works

Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward

Hsu, D. C., & Marshall, G. A. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160930112125 · Cited by 93 · see citing works

Prevalence of Early Dementia After First-Ever Stroke

Béjot, Y., Aboa-Éboulé, C., Durier, J., Rouaud, O., Jacquin, A., Ponavoy, E., Richard, D., Moreau, T., & Giroud, M. (2011) · Stroke · doi:10.1161/strokeaha.110.595553 · Cited by 91 · see citing works

Statins for the treatment of dementia

McGuinness, B., O’Hare, J., Craig, D., Bullock, R. A., Malouf, R. S., & Passmore, P. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007514.pub2 · Cited by 92 · see citing works

Dietary fats, cerebrovasculature integrity and Alzheimer’s disease risk

Takechi, R., Galloway, S., Pallebage‐Gamarallage, M. M., Lam, V., & Mamo, J. C. L. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.10.004 · Cited by 88 · see citing works

Respiratory Disease and Lower Pulmonary Function as Risk Factors for Dementia

Russ, T. C., Mika Kivimaki, B., & Batty, G. D. (2020) · CHEST Journal · doi:10.1016/j.chest.2019.12.012 · Cited by 86 · see citing works

Statins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review

Alsubaie, N., Al-Kuraishy, H. M., Al-Gareeb, A. I., Alharbi, B., WAARD, M. M. D., Sabatier, J., Saad, ‏. M., & Batiha, G. E. (2022) · Brain Sciences · doi:10.3390/brainsci12101290 · Cited by 86 · see citing works

Cholesterol-independent neuroprotective and neurotoxic activities of statins: Perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders

Butterfield, D. A., Barone, E., & Mancuso, C. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.04.007 · Cited by 80 · see citing works

The relationship between midlife dyslipidemia and lifetime incidence of dementia: A systematic review and meta‐analysis of cohort studies

Wee, J., Sukudom, S., Bhat, S., Marklund, M., Peiris, N. J., Hoyos, C. M., Patel, S., Naismith, S. L., Dwivedi, G., & Misra, A. (2023) · Alzheimer's &amp; Dementia: Diagnosis, Assessment &amp; Disease Monitoring · doi:10.1002/dad2.12395 · Cited by 82 · see citing works

Symptomatic and Nonamyloid/Tau Based Pharmacologic Treatment for Alzheimer DiseasePreprint

Aisen, P. S. S., Cummings, J. L., & Schneider, L. S. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006395 · Cited by 82 · see citing works

Lipid Lowering Agents, Cognitive Decline, and Dementia: The Three-City Study

Ancelin, M., Carrière, I., Barberger‐Gateau, P., Auriacombe, S., Rouaud, O., Fourlanos, S., Berr, C., Dupuy, A., & Ritchie, K. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120064 · Cited by 81 · see citing works

Vascular pathology: Cause or effect in Alzheimer disease?

Rius‐Pérez, S., Tormos, A. M., Pérez, S., & Taléns‐Visconti, R. (2017) · Neurología (English Edition) · doi:10.1016/j.nrleng.2015.07.008 · Cited by 75 · see citing works

Depression as a Risk Factor for Dementia and Alzheimer’s Disease

Cantón-Habas, V., Rich‐Ruiz, M., Romero‐Saldaña, M., & Carrera-González, M. P. (2020) · Biomedicines · doi:10.3390/biomedicines8110457 · Cited by 75 · see citing works

Statins and Brain Dysfunction

Morandi, A., Hughes, C. G., Girard, T. D., McAuley, D. F., Ely, E. W., & Pandharipande, P. P. (2011) · CHEST Journal · doi:10.1378/chest.10-3065 · Cited by 70 · see citing works

Patología vascular: ¿causa o efecto en la enfermedad de Alzheimer?

Rius‐Pérez, S., Tormos, A. M., Pérez, S., & Taléns‐Visconti, R. (2015) · Neurología · doi:10.1016/j.nrl.2015.07.010 · Cited by 70 · see citing works

Markers of cholesterol transport are associated with amyloid deposition in the brain

Hughes, T. M., López, O. L., Evans, R. G., Kamboh, M. I., Williamson, J. D., Klunk, W. E., Mathis, C. A., Price, J. C., Cohen, A. D., Snitz, B. E., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.040 · Cited by 65 · see citing works

Cochrane review on ‘Statins for the treatment of dementia’

McGuinness, B., O’Hare, J., Craig, D., Bullock, R. A., Malouf, R. S., & Passmore, P. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3797 · Cited by 64 · see citing works

Cognitive impairment and cardiovascular disease: So near, so far

Picano, E., Bruno, R. M., Ferrari, G. F., & Bonuccelli, U. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.05.004 · Cited by 64 · see citing works

Markers of Cholesterol Metabolism in the Brain Show Stronger Associations with Cerebrovascular Disease than Alzheimer's Disease

Hughes, T. M., Kuller, L. H., López, O. L., Becker, J. T., Evans, R. G., Sutton-Tyrrell, K., & Rosano, C. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111460 · Cited by 64 · see citing works

Smoking, hypercholesterolaemia and hypertension as risk factors for cognitive impairment in older adults

Okusaga, O. O., Stewart, M. C. W., Butcher, I., Deary, I. J., Fowkes, F. G. R., & Price, J. F. (2013) · Age and Ageing · doi:10.1093/ageing/afs193 · Cited by 63 · see citing works

Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes

Caselli, R. J., Dueck, A. C., Locke, D. E. C., Sabbagh, M. N., Ahern, G. L., Rapcsak, S. Z., Baxter, L. C., Yaari, R., Woodruff, B. K., Hoffman‐Snyder, C., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318211c3ae · Cited by 59 · see citing works

Prospects for delaying the rising tide of worldwide, late-life dementias

Larson, E. B. (2010) · International Psychogeriatrics · doi:10.1017/s1041610210001080 · Cited by 56 · see citing works

Mild cognitive decline. A position statement of the Cognitive Decline Group of the European Innovation Partnership for Active and Healthy Ageing (EIPAHA)

Apóstolo, J., Holland, C., O’Connell, M. D. L., Feeney, J. C., Tabarés‐Seisdedos, R., Tadros, G., Campos, E. B., Santos, N. C., Robertson, D. A., Marcucci, M., et al. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.10.008 · Cited by 56 · see citing works

Alzheimer’s disease in people with Down’s syndrome: the prospects for and the challenges of developing preventative treatments

Castro, P., Zaman, S. H., & Holland, A. J. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8308-8 · Cited by 55 · see citing works

SUPPORT Tools for evidence-informed health Policymaking (STP) 8: Deciding how much confidence to place in a systematic review

Lewin, S. A., Oxman, A. D., Lavis, J. N., & Fretheim, A. (2009) · Health Research Policy and Systems · doi:10.1186/1478-4505-7-s1-s8 · Cited by 56 · see citing works

Integrating Health into Cognitive Aging: Toward a Preventive Cognitive Neuroscience of Aging

Spiro, A., & Brady, C. B. (2011) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbr018 · Cited by 53 · see citing works

Statin use and incident dementia: A nationwide cohort study of Taiwan

Chou, C., Chou, Y., Chou, Y., Yang, Y.-F., & Huang, N. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.03.018 · Cited by 47 · see citing works

The Consortium for the early identification of Alzheimer's disease–Quebec (CIMA‐Q)

Belleville, S., LeBlanc, A. C., Kergoat, M., Calon, F., Gaudreau, P., Sébastien, H., Hudon, C., Leclerc, N. M., Mechawar, N., Duchesne, S., et al. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.07.003 · Cited by 47 · see citing works

Cardiovascular Risk Factors, Cerebrovascular Disease Burden, and Healthy Brain Aging

Flicker, L. A. (2010) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2009.12.005 · Cited by 44 · see citing works

Do statins prevent Alzheimer's disease? A narrative review

Daneschvar, H. L., Aronson, M. D., & Smetana, G. W. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.08.012 · Cited by 42 · see citing works

Dementia and osteoporosis in a geriatric population: Is there a common link?

Downey, C. L., Young, A., Burton, E., Graham, S. M., MacFarlane, R. J., Tsapakis, E.-M., & Tsiridis, E. E. (2017) · World Journal of Orthopedics · doi:10.5312/wjo.v8.i5.412 · Cited by 42 · see citing works

Flow-Mediated Dilation and Neurocognition

Naiberg, M. R., Newton, D. F., & Goldstein, B. I. (2015) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000266 · Cited by 42 · see citing works

Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline

Zanchetti, A., Liu, L., Mancia, G., Parati, G., Grassi, G. M., Stramba‐Badiale, M., Silani, V., Bilo, G., Corrao, G., Zambon, A., et al. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000253 · Cited by 39 · see citing works

Statins in older adults

Hilmer, S. N., & Gnjidic, D. (2013) · Australian Prescriber · doi:10.18773/austprescr.2013.034 · Cited by 39 · see citing works

Cognitive Effects of Statin Medications

Kelley, B. J., & Glasser, S. P. (2014) · CNS Drugs · doi:10.1007/s40263-014-0147-5 · Cited by 38 · see citing works

Cognitive Impairment and Age-Related Vision Disorders: Their Possible Relationship and the Evaluation of the Use of Aspirin and Statins in a 65 Years-and-Over Sardinian Population

Mandas, A., Mereu, R. M., Catte, O., Saba, A., Serchisu, L., Costaggiu, D., Peiretti, E., Caminiti, G., Vinci, M., Casu, M., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00309 · Cited by 37 · see citing works

Reversal of age-associated memory impairment by rosuvastatin in rats

Rech, R. L., de Lima, M. N. M., Dornelles, A., Garcia, V. A., Alcalde, L. A., Vedana, G., & Schröder, N. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.02.001 · Cited by 35 · see citing works

Statins in Neurological Disorders: Mechanisms and Therapeutic Value

Reiss, A. B., & Wirkowski, E. J. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.141 · Cited by 35 · see citing works

Systemic and Central Immunity in Alzheimer's Disease: Therapeutic Implications

Butchart, J., & Holmes, C. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00245.x · Cited by 35 · see citing works

Hypertension and Risk of Post-Operative Cognitive Dysfunction (POCD): A Systematic Review and Meta-Analysis

Feinkohl, I., Winterer, G., & Pischon, T. (2017) · Clinical Practice and Epidemiology in Mental Health · doi:10.2174/1745017901713010027 · Cited by 35 · see citing works

Dietary manipulation and caloric restriction in the development of mouse models relevant to neurological diseases

Schroeder, J. E., Richardson, J. C., & Virley, D. J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.04.007 · Cited by 34 · see citing works

Cholesterol and LDL Relate to Neuritic Plaques and to APOE4 Presence but Not to Neurofibrillary Tangles

Lesser, G. T., Beeri, M. S., Schmeidler, J., Purohit, D. P., & Haroutunian, V. (2011) · Current Alzheimer Research · doi:10.2174/156720511795563755 · Cited by 34 · see citing works

Remembering Statins: Do Statins Have Adverse Cognitive Effects?

Bitzur, R. (2016) · Diabetes Care · doi:10.2337/dcs15-3022 · Cited by 33 · see citing works

Impact of a multi-nutrient diet on cognition, brain metabolism, hemodynamics, and plasticity in apoE4 carrier and apoE knockout mice

Jansen, D., Zerbi, V., Janssen, C. I. F., van Rooij, D., Zinnhardt, B., Dederen, P. J. W. C., Wright, A. J., Broersen, L. M., Lütjohann, D., Heerschap, A., et al. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0606-7 · Cited by 32 · see citing works

Three midlife strategies to prevent cognitive impairment due to Alzheimer's disease

Henderson, V. W. (2014) · Climacteric · doi:10.3109/13697137.2014.929650 · Cited by 31 · see citing works

Alternative Drug Therapies for Dementia

Howland, R. H. (2011) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20110407-03 · Cited by 31 · see citing works

Impaired Orthotopic Glioma Growth and Vascularization in Transgenic Mouse Models of Alzheimer's Disease

Paris, D., Ganey, N., Banasiak, M., Laporte, V., Patel, N., Mullan, M., Murphy, S. F., Yee, G.-T., Bachmeier, C., Ganey, C., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2586-10.2010 · Cited by 30 · see citing works

Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes

Feinkohl, I., Keller, M., Robertson, C. M., Morling, J. R., McLachlan, S., Frier, B. M., Deary, I. J., Strachan, M. W. J., & Price, J. F. (2015) · Diabetologia · doi:10.1007/s00125-015-3581-0 · Cited by 30 · see citing works

Exploring new indications for statins beyond atherosclerosis: Successes and setbacks

Waters, D. D. (2010) · Journal of Cardiology · doi:10.1016/j.jjcc.2009.12.003 · Cited by 27 · see citing works

Lost in Translation

Ganguli, M., & Kukull, W. A. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.311 · Cited by 28 · see citing works

Towards onset prevention of cognition decline in adults with Down syndrome (The TOP-COG study): A pilot randomised controlled trial

Cooper, S., Ademola, T., CASLAKE, M. J., Douglas, E. A., Evans, J. J., Greenlaw, N., Haig, C. E., Hassiotis, A., Jahoda, A. J., McConnachie, A., et al. (2016) · Trials · doi:10.1186/s13063-016-1370-9 · Cited by 27 · see citing works

Methodologic issues in clinical trials for prevention or risk reduction in osteoarthritis

Jordan, J. M., Sowers, M., Messier, S. P., Bradley, J., Arangio, G. A., Katz, J. N., Losina, E., Rovati, L. C., Bachtell, N., Cooper, C. C., et al. (2011) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.10.031 · Cited by 26 · see citing works

Reduction of Long‐Term Care Dependence After an 8‐Year Primary Care Prevention Program for Stroke and Dementia: The INVADE Trial

Bickel, H., Ander, K., Brönner, M., Etgen, T., Gnahn, H., Gotzler, O., Poppert, H., Pürner, K., Sander, D., & Förstl, H. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.000786 · Cited by 26 · see citing works

Atorvastatin improved scopolamine-induced impairment in memory acquisition in mice: Involvement of nitric oxide

Paydar, M. J., Rayatnia, F., Fakhraei, N., Zakeri, M., Mirazi, N., Norouzi, A., & Dehpour, A. R. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.057 · Cited by 25 · see citing works

Safety and Effectiveness of Statins for Prevention of Recurrent Myocardial Infarction in 12 156 Typical Older Patients: A Quasi-Experimental Study

Blè, A., Hughes, P. M., Delgado, J., Masoli, J. A. H., Bowman, K., Zirk‐Sadowski, J., Mújica-Mota, R., Henley, W., & Melzer, D. R. (2016) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw082 · Cited by 25 · see citing works

Newly diagnosed type 2 diabetes and risk of dementia: A population-based 7-year follow-up study in Taiwan

Cheng, P., Sy, H., Wu, S., Wang, W., & Chen, Y. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.06.003 · Cited by 25 · see citing works

Hypercholesterolemia and the Increased Risk of Vascular Dementia: a Cholesterol Perspective

Shang, G., Shao, Q., Lv, K., Xu, W., Ji, J., Fan, S., Kang, X., Cheng, F., Wang, X., & Wang, Q. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01217-3 · Cited by 24 · see citing works

Statins and their effect on cognition: Let’s clear up the confusion

Gauthier, J. M., & Massicotte, A. (2015) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163515578692 · Cited by 23 · see citing works

Subclinical carotid atherosclerosis and cognitive function

Arntzen, K. A., & Mathiesen, E. B. (2011) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2011.01538.x · Cited by 22 · see citing works

Association of Blood MicroRNA Expression and Polymorphisms with Cognitive and Biomarker Changes in Older Adults

Sadlon, A., Takousis, P., Εvangelou, Ε., Prokopenko, I., Alexopoulos, P., Udeh‐Momoh, C. T., Price, G. J., Middleton, L. T., & Perneczky, R. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.99 · Cited by 21 · see citing works

Exploration of 100 commonly used drugs and supplements on cognition in older adults

Obermann, K. R., Morris, J. C., & Roe, C. M. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.12.002 · Cited by 21 · see citing works

Latest advances on interventions that may prevent, delay or ameliorate dementia

Wilson, D., Peters, R. K., Ritchie, K. A., & Ritchie, C. W. (2011) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622310397636 · Cited by 19 · see citing works

Primary Prevention of Cardiovascular Disease in Older Adults

Barry, A. R., O’Neill, D. E., & Graham, M. M. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.01.032 · Cited by 20 · see citing works

Prevention of Poststroke Cognitive Decline: ASPIS – a Multicenter, Randomized, Observer-Blind, Parallel Group Clinical Trial to Evaluate Multiple Lifestyle Interventions – Study Design and Baseline Characteristics

Brainin, M., Matz, K., Nemec, M., Teuschl, Y., Dachenhausen, A., Asenbaum-Nan, S., Bancher, C., Kepplinger, B., Oberndorfer, S., Pinter, M. M., et al. (2013) · International Journal of Stroke · doi:10.1111/ijs.12188 · Cited by 20 · see citing works

P2‐400: Statins for the prevention of Alzheimer's disease and dementia

McGuinness, B., Lau, L., Craig, D., Bullock, R. A., & Passmore, P. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.1478

P3‐391: Statins for the treatment of dementia

McGuinness, B., O’Hare, J., Bullock, R. A., Malouf, R. S., Craig, D., & Passmore, P. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.1933 · Cited by 40 · see citing works

Statins for the treatment of dementia

McGuinness, B., O’Hare, J., Craig, D., Bullock, R. A., Malouf, R. S., & Passmore, P. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007514.pub2 · Cited by 92 · see citing works

Statins for the prevention of Alzheimer's disease and dementia

Scott, H. D., & Laake, K. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003160 · Cited by 91 · see citing works

Benefits and Harms of Statins in People with Dementia: A Systematic Review and Meta‐Analysis

Davis, K. A. S., Bishara, D., Perera, G., Molokhia, M., Rajendran, L., & Stewart, R. J. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16342 · Cited by 27 · see citing works